Mark For: ZYREXAL® trademark registration is intended to cover the categories of
Research | OneLook Acronym Finder |
Serial Number | 88166503 |
Registration Number | 6719189 |
Mark Literal Elements | ZYREXAL |
Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
Mark Type | TRADEMARK |
Register | PRINCIPAL |
Current Location | INTENT TO USE SECTION 2019-08-27 |
Basis | 1(b) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | No |
Intent To Use | Yes |
Filed ITU | Yes |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Marc Hankin |
Law Office Assigned | L80 |
Employee Name | BUSH, KAREN K |
2018-10-23 | Application Filed |
2019-01-18 | Location: PUBLICATION AND ISSUE SECTION |
2019-01-18 | Status: Live/Pending |
2019-02-06 | Transaction Date |
2019-02-26 | Published |
2019-02-26 | Published for Opposition |
2019-08-27 | Location: INTENT TO USE SECTION |
2021-02-27 | Status: A third request for extension of time to file a Statement of Use has been granted. |
2022-05-03 | Trademark Registered |
Party: | Vivera Pharmaceuticals, Inc. |
Address | 4533 MacArthur Blvd., #5049 Newport Beach, CALIFORNIA UNITED STATES 92660 |
Legal Entity Type | Corporation |
Legal Entity State | DELAWARE |
Drawing | JPEG | 2018-10-23 |
TEAS Plus New Application | MULTI | 2018-10-23 |
XSearch Search Summary | XML | 2019-01-16 |
TRAM Snapshot of App at Pub for Oppostn | MULTI | 2019-01-18 |
Notice of Publication | XML | 2019-02-06 |
Notification Of Notice of Publication | XML | 2019-02-06 |
OG Publication Confirmation | XML | 2019-02-26 |
TEAS Rev, App and/or COA of Atty/Dom.Rep | XML | 2019-04-22 |
Post Publication Amendment | XML | 2019-06-20 |
Amendment and Mail Process Complete | MULTI | 2019-07-18 |
Notice of Allowance | XML | 2019-08-27 |
TEAS Rev, App and/or COA of Atty/Dom.Rep | MULTI | 2019-11-13 |
Extension of Time to File SOU | MULTI | 2020-02-27 |
ITU Extension Approval | APPLICATION/XML | 2020-02-29 |
ITU Unit Action | MULTI | 2020-02-29 |
Extension of Time to File SOU | MULTI | 2020-08-27 |
ITU Extension Approval | APPLICATION/XML | 2020-08-29 |
ITU Unit Action | MULTI | 2020-08-29 |
TEAS Withdrawal of Attorney | XML | 2020-10-08 |
Change Address or Representation Form | XML | 2021-02-25 |
Extension of Time to File SOU | APPLICATION/XML | 2021-02-27 |
ITU Extension Approval | APPLICATION/XML | 2021-03-02 |
ITU Unit Action | MULTI | 2021-03-02 |
IC 005. US 006 018 044 046 051 052. G & S: Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of prescription dosage capsules that facilitate the delivery of pharmaceutical preparations; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; all of the foregoing excluding pharmaceutical preparations and substances for the treatment of the central nervous system, sleep disorders, and neurological diseases or disorders
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
Type Code | Type |
---|---|
GS0051 | Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of prescription dosage capsules that facilitate the delivery of pharmaceutical preparations; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents |
GS0051 | Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of prescription dosage capsules that facilitate the delivery of pharmaceutical preparations; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; all of the foregoing excluding pharmaceutical preparations and substances for the treatment of the central nervous system, sleep disorders, and neurological diseases or disorders |
Description | Date | Proceeding Number |
---|---|---|
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2021-03-02 | |
TEAS EXTENSION RECEIVED | 2021-02-27 | |
EXTENSION 3 GRANTED | 2021-02-27 | 98765 |
EXTENSION 3 FILED | 2021-02-27 | 98765 |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2021-02-25 | |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2021-02-25 | |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2021-02-25 | |
WITHDRAWAL OF ATTORNEY GRANTED | 2020-10-08 | |
TEAS WITHDRAWAL OF ATTORNEY RECEIVED | 2020-10-08 | |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-08-29 | |
TEAS EXTENSION RECEIVED | 2020-08-27 | |
EXTENSION 2 GRANTED | 2020-08-27 | 98765 |
EXTENSION 2 FILED | 2020-08-27 | 98765 |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-02-29 | |
TEAS EXTENSION RECEIVED | 2020-02-27 | |
EXTENSION 1 GRANTED | 2020-02-27 | 98765 |
EXTENSION 1 FILED | 2020-02-27 | 98765 |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2019-11-13 | |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2019-11-13 | |
NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2019-08-27 | |
CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED | 2019-07-17 | 86882 |
ASSIGNED TO PETITION STAFF | 2019-07-11 | 86882 |
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | 2019-07-07 | |
TEAS POST PUBLICATION AMENDMENT RECEIVED | 2019-06-20 | 1111 |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2019-04-22 | |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2019-04-22 | |
EXTENSION OF TIME TO OPPOSE RECEIVED | 2019-03-28 | |
PUBLISHED FOR OPPOSITION | 2019-02-26 | |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2019-02-26 | |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2019-02-06 | |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2019-01-17 | |
ASSIGNED TO EXAMINER | 2019-01-15 | 67516 |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2018-11-05 | |
NEW APPLICATION ENTERED IN TRAM | 2018-10-26 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.